WallStSmart
ELUT

Elutia Inc.

NASDAQ: ELUT · HEALTHCARE · MEDICAL DEVICES

$1.06
-4.89% today

Updated 2026-06-05

Market cap
$46.86M
P/E ratio
P/S ratio
3.52x
EPS (TTM)
$-0.65
Dividend yield
52W range
$1 – $3
Volume
0.1M

Elutia Inc. (ELUT) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20182019202020212022202320242025
Operating cash flow$-5.13M$-7.22M$-13.63M$-15.45M$-21.43M$-21.76M$-22.66M$-44.81M
Capital expenditures$190000.00$577000.00$640000.00$369000.00$540000.00$346000.00$654000.00$1.88M
Depreciation
Stock-based comp$208000.00$779000.00$3.54M$3.65M$2.44M$7.89M$4.40M
Free cash flow$-5.32M$-7.80M$-14.27M$-15.81M$-21.97M$-22.11M$-23.31M$-46.69M
Investing cash flow
Financing cash flow
Dividends paid
Share repurchases
Debt repayment
Net change in cash

Frequently asked questions

What is Elutia Inc.'s revenue?

Elutia Inc.'s trailing twelve-month revenue is $12.46M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is ELUT?

In its most recent fiscal year, ELUT ran a gross margin of 53.66%, an operating margin of -149.78%, and a net margin of 434.23%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does ELUT generate?

ELUT produced $-46.69M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is ELUT's balance sheet healthy?

ELUT holds $36.35M in cash and equivalents against — in long-term debt, on $27.67M of shareholder equity. That debt is best read against the cash flow the business throws off each year.